First Derivatives plc (FDP):企業の財務・戦略的SWOT分析

◆英語タイトル:First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2938
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

First Derivatives plc (FDP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

First Derivatives plc (FD) provides consulting services across technology, pharma, manufacturing, finance, energy, and retail industries. The company also offers consulting services in capital market sector by leveraging Kx technology and software services in licensing of intellectual property and related services. Its major products include software and database solutions and services include consulting services and technology services. It markets its products and services under MRP Prelytix brand. The company operates in three industries: FinTech, MarTech, and Other markets. FD sells its products and services under direct sales model. Geographically, the company operates in North America, the UK, Rest of Europe, and Australasia. FD is headquartered at Newry, the UK.

First Derivatives plc Key Recent Developments

Jan 15,2018: First Derivatives Appoints Ex-IBM Executive Donna Troy as Non-Executive
Nov 08,2017: Tech giant First Derivatives to hire hundreds more after a robust year
May 16,2017: First Derivatives reports results for the year ended 28th february 2017
May 15,2017: First Derivatives: Appointment and Directorate change
May 15,2017: First Derivatives appoints Jon Robson executive vice-president

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
First Derivatives plc – Key Facts 6
First Derivatives plc – Key Employees 7
First Derivatives plc – Key Employee Biographies 8
First Derivatives plc – Major Products and Services 9
First Derivatives plc – History 10
First Derivatives plc – Company Statement 13
First Derivatives plc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Affiliate 16
Section 2 – Company Analysis 17
Company Overview 17
First Derivatives plc – Business Description 18
Business Segment: Managed services and consulting 18
Overview 18
Performance 18
Business Segment: Software 18
Overview 18
Performance 18
Geographical Segment: Australasia 18
Performance 18
Geographical Segment: North America 18
Performance 18
Geographical Segment: Rest of Europe 18
Performance 18
Geographical Segment: The UK 19
Performance 19
R&D Overview 19
First Derivatives plc – Corporate Strategy 20
First Derivatives plc – SWOT Analysis 21
SWOT Analysis – Overview 21
First Derivatives plc – Strengths 21
First Derivatives plc – Weaknesses 22
First Derivatives plc – Opportunities 23
First Derivatives plc – Threats 24
First Derivatives plc – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Recent Developments 33
Jan 15, 2018: First Derivatives Appoints Ex-IBM Executive Donna Troy as Non-Executive 33
May 16, 2017: First Derivatives reports results for the year ended 28th february 2017 34
Section 5 – Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
First Derivatives plc, Key Facts 6
First Derivatives plc, Key Employees 7
First Derivatives plc, Key Employee Biographies 8
First Derivatives plc, Major Products and Services 9
First Derivatives plc, History 10
First Derivatives plc, Other Locations 14
First Derivatives plc, Subsidiaries 15
First Derivatives plc, Affiliate 16
First Derivatives plc, Key Competitors 25
First Derivatives plc, Ratios based on current share price 26
First Derivatives plc, Annual Ratios 27
First Derivatives plc, Annual Ratios (Cont...1) 28
First Derivatives plc, Annual Ratios (Cont...2) 29
First Derivatives plc, Interim Ratios 31
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List of Figures
First Derivatives plc, Performance Chart (2014 - 2018) 30
First Derivatives plc, Ratio Charts 32

★海外企業調査レポート[First Derivatives plc (FDP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kumba Iron Ore Ltd:企業の戦略・SWOT・財務情報
    Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report Summary Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Formosa Chemicals & Fibre Corp (1326):企業の財務・戦略的SWOT分析
    Formosa Chemicals & Fibre Corp (1326) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Meiji Seika Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Meiji Seika Pharma Co Ltd (Meiji Seika Pharma), a subsidiary of Meiji Holdings Co Ltd, is a pharmaceutical solutions provider that carries out manufacturing and sale of ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company provides Streptomycin Meiji, Kanamycin Me …
  • Keryx Biopharmaceuticals Inc (KERX):製薬・医療:M&Aディール及び事業提携情報
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • EyeGate Pharmaceuticals Inc (EYEG)-製薬・医療分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Kina Petroleum Ltd (KPL)-石油・ガス分野:企業M&A・提携分析
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Mayo Clinic:製薬・医療:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • ABN AMRO Group NV (ABN):企業の財務・戦略的SWOT分析
    ABN AMRO Group NV (ABN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • IDT Corporation:企業の戦略・SWOT・財務情報
    IDT Corporation - Strategy, SWOT and Corporate Finance Report Summary IDT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) operates as a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, electronic laparoscope devices, neurova …
  • Leap Therapeutics Inc (LPTX):医療機器:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • MILEI GmbH:企業の戦略・SWOT・財務情報
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Medical University of Vienna-製薬・医療分野:企業M&A・提携分析
    Summary Medical University of Vienna (MUV) is a medical research institute that offers educational services. The institute provides research and education services in the field of medical science. Its research services include project submission, clinical and preclinical studies, research funding, b …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Immusoft Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Immusoft Corp (Immusoft) is a biotechnology start-up company that focuses on the development of autologous cell therapy platform for the treatment of genetic diseases. The company’s technology includes immune system programming (ISP) technology, gene delivery technology and lymphopoiesis cul …
  • Medytox Inc (086900):企業の財務・戦略的SWOT分析
    Summary Medytox Inc (Medytox) develops, manufactures and markets biopharmaceutical products. Its products include botulinum toxin type A product, hyaluronic acid filler, medical devices, prescription cream, toxin detection kits and antitoxin therapeutics for treating skin disorders. The company is a …
  • Women’s Choice Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that provides branded prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diab …
  • QIAGEN N.V.:企業のM&A・事業提携・投資動向
    QIAGEN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QIAGEN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Euskaltel, S.A. (EKT):企業の財務・戦略的SWOT分析
    Euskaltel, S.A. (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆